Teleflex Incorporated (TFX) Shares Bought by First Trust Advisors LP
First Trust Advisors LP increased its stake in Teleflex Incorporated (NYSE:TFX) by 55.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 74,551 shares of the medical technology company’s stock after buying an additional 26,666 shares during the period. First Trust Advisors LP owned 0.17% of Teleflex worth $15,489,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. FMR LLC raised its stake in shares of Teleflex by 46.5% in the first quarter. FMR LLC now owns 811,764 shares of the medical technology company’s stock valued at $157,263,000 after buying an additional 257,649 shares during the last quarter. MARSHALL WACE ASIA Ltd bought a new stake in shares of Teleflex during the first quarter valued at about $42,368,000. Marshall Wace North America L.P. bought a new stake in shares of Teleflex during the first quarter valued at about $42,368,000. Vanguard Group Inc. raised its stake in shares of Teleflex by 5.2% in the first quarter. Vanguard Group Inc. now owns 3,781,475 shares of the medical technology company’s stock valued at $732,584,000 after buying an additional 186,845 shares during the last quarter. Finally, Copper Rock Capital Partners LLC bought a new stake in shares of Teleflex during the second quarter valued at about $21,709,000. Institutional investors own 92.59% of the company’s stock.
Teleflex Incorporated (NYSE:TFX) opened at 211.77 on Tuesday. The stock has a market capitalization of $9.54 billion, a price-to-earnings ratio of 40.50 and a beta of 1.05. Teleflex Incorporated has a 1-year low of $136.53 and a 1-year high of $217.97. The company has a 50-day moving average of $210.17 and a 200-day moving average of $199.29.
Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.91 by $0.13. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The business had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. During the same period last year, the firm earned $1.89 earnings per share. The company’s quarterly revenue was up 11.6% on a year-over-year basis. Analysts anticipate that Teleflex Incorporated will post $8.28 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Tuesday, August 15th will be given a $0.34 dividend. The ex-dividend date is Friday, August 11th. This represents a $1.36 annualized dividend and a yield of 0.64%. Teleflex’s payout ratio is presently 26.00%.
COPYRIGHT VIOLATION NOTICE: This piece was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/08/22/teleflex-incorporated-tfx-shares-bought-by-first-trust-advisors-lp.html.
TFX has been the subject of a number of recent research reports. Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $228.00 price objective for the company in a research note on Friday, June 23rd. Barclays PLC reiterated a “buy” rating on shares of Teleflex in a research note on Monday, June 26th. Deutsche Bank AG lifted their price objective on shares of Teleflex from $213.00 to $220.00 and gave the company a “buy” rating in a research note on Monday, May 8th. Needham & Company LLC reiterated a “buy” rating and issued a $224.00 price objective on shares of Teleflex in a research note on Friday, May 5th. Finally, Leerink Swann lifted their price objective on shares of Teleflex from $215.00 to $220.00 and gave the company a “market perform” rating in a research note on Friday, June 9th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the stock. Teleflex has an average rating of “Buy” and a consensus price target of $228.00.
In other Teleflex news, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $208.41, for a total value of $41,682.00. Following the transaction, the director now directly owns 8,080 shares in the company, valued at $1,683,952.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gretchen R. Haggerty purchased 1,000 shares of the firm’s stock in a transaction on Wednesday, June 21st. The stock was acquired at an average price of $203.82 per share, for a total transaction of $203,820.00. Following the completion of the transaction, the director now directly owns 1,760 shares of the company’s stock, valued at approximately $358,723.20. The disclosure for this purchase can be found here. Insiders sold 3,100 shares of company stock worth $637,463 over the last quarter. Insiders own 2.39% of the company’s stock.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.